Ecallantide: final HAE patient treated in the second phase III trial
KeywordsClinical Trial Medium Release Acute Attack Angioedema Threatening Condition
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
© Adis International Ltd 2008